Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reumatocept vs Enbrel in Rheumatoid Arthritis
NCT01394913Phase 3Withdrawn
- Sponsor
- EMS
- Start
- Aug 2013
- Primary completion
- Mar 2014
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of GP2015 in rheumatoid arthritis (RA), sponsored by EMS. Planned start Aug 2013; status: withdrawn.
02
Drugs
GP2015
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01394913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01394913.